Listed

Rigel Pharmaceuticals Inc: Form 10-K for the period ended Dec 31, 2021

Filed with the SEC on Mar 1, 2022 and accepted by EDGAR at Mar 1, 2022, 16:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2021-01-01 to 2021-12-31$149.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2021-01-01 to 2021-12-31$1.1mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative12 months2021-01-01 to 2021-12-31$91.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2021-01-01 to 2021-12-31−$12.5mus-gaap:OperatingIncomeLoss
Interest expense12 months2021-01-01 to 2021-12-31$4.9mus-gaap:InterestExpense
Income tax12 months2021-01-01 to 2021-12-31$605.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2021-01-01 to 2021-12-31−$17.9mus-gaap:NetIncomeLoss
Diluted EPS12 months2021-01-01 to 2021-12-31−$0.11us-gaap:EarningsPerShareDiluted
Basic EPS12 months2021-01-01 to 2021-12-31−$0.11us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2021-01-01 to 2021-12-31170,492,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2021-01-01 to 2021-12-31$5.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2021-01-01 to 2021-12-31$627.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-12-31$18.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-12-31$154.5mus-gaap:AssetsCurrent
Total assetsAt period end2021-12-31$167.3mus-gaap:Assets
Current liabilitiesAt period end2021-12-31$63.6mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2021-12-31$20.0mus-gaap:LongTermDebt
Shareholders' equityAt period end2021-12-31$30.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-22-002551. Last ingested by Listed: Nov 14, 2026, 23:09 ET. Listed shows no prices and gives no investment advice.